Comparison of clinical efficacy of SST analogues therapy (lanreotide autogel vs. octreotide LAR) in treatment of patients with advance, non-resectable pancreatic neuroendocrine tumours (pNETs)

Background: Use of somatostatin analogues can be considered in pancreatic NET G1/G2 as a first-line therapy. This retrospective study aimed to compare the efficacy of octreotide long-acting release (OCT) and lanreotide Autogel (LAN) in patient with advanced G1/G2 pNETs, comparison between LAN and OCT in naïve patients, based on progression free survival (PFS). Methods: Ninety-two patients with histological proven G1 or G2 pNETs were...